Prognostic factors for overall survival in patients with metastatic castration-resistant prostate cancer: Secondary analysis. This is an ASCO Meeting Abstract from the 2017 Genitourinary Cancers ...
HHV-8 positive clinically advanced castrate-resistant prostate cancer (mCRPC): A potentially distinct molecular subset.
Source: Getty Images Biopsy Gleason patterns 4+5, 5+4, and 5+5 should be given separate consideration in pretreatment risk stratification, according to investigators. Prostate cancer (PCa) survival ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results